Clinical Trials Directory

Trials / Unknown

UnknownNCT05034861

COmputerized CTG Self-MOnitoring Versus Standard Doppler Assessment in Late-onset FGR: COSMOS Study

COmputerized CTG Self-MOnitoring Versus Standard Doppler Assessment in Late-onset FGR: Study Protocol for a Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Institute of Mother and Child, Warsaw, Poland · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Fetal growth restriction is one of the major causes of perinatal morbidity, mortality and adverse neurological outcome. Growth restricted fetuses do not reach their potential due to multiple factors. Although early (\<32 weeks' gestation) FGR is associated with the highest risk of adverse outcomes, late FGR (≤ 32 weeks' gestation) is more common in daily maternal-fetal medicine care. Despite its' prevalence, optimal standard for monitoring differs between the centers and may be difficult in case of limited access to advanced perinatal care. We present a protocol for COmputerized CTG Self-MOnitoring versus Standard Doppler assessment in Late-onset FGR (COSMOS) trial, which is a prospective, cross-over, open-label and randomized trial that compares two different protocols for late-onset FGR observation. All women carrying fetuses with late-onset FGR with positive end-diastolic flow in umbilical artery will be invited to participate in the randomized trial. Patients will be randomly divided into two groups: CTG - a group that will receive electronic device for cCTG home assessment, and Doppler - a group that will be monitored according to standard Doppler velocimetry criteria. Further management will depend on the arm of the study. Pregnancy and neonatal outcomes will be collected and analyzed.

Conditions

Interventions

TypeNameDescription
DEVICEcCTGSelf-applied home computerized CTG device used twice weekly instead of standard Doppler assessment once weekly.
DIAGNOSTIC_TESTDopplerStandard Doppler assessment provided once weekly in case of late FGR with positive end diastolic flow in the umbilical artery.

Timeline

Start date
2022-12-13
Primary completion
2024-10-01
Completion
2024-12-01
First posted
2021-09-05
Last updated
2022-12-15

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT05034861. Inclusion in this directory is not an endorsement.